Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer: A Systematic Review
Dora et al, Journal of Endourology (2022)
Read the publication
Treat a wider spectrum of prostate cancer and BPH patients—and help them maintain their quality of life.
Transurethral Ultrasound Ablation of the Prostate (TULSA-PRO®) is an innovative AI treatment that uses real-time MRI imaging and physician-controlled robotics to ensure incredibly accurate and precise treatment delivery.
Proven In
3000+
Procedures
The TULSA-PRO Difference
Transurethral Ultrasound
Ten parallel beams of ultrasound energy from a rotating applicator provide efficient ablation of small/large/diffuse targets in any part of the prostate—for BPH or cancer.
- Incision-free
- No energy through rectum and no needles
- Can treat most regions and sizes of prostate
Real-time MRI Robotics with AI
- AI treatment planning
- Physician-controlled robotics
- “Closed loop” temperature system
Gentle Prostate Heating
- No procedural blood loss
- No overnight stay
- Utilizes urethra and rectal cooling
Explore more about TULSA-PRO
Highly Flexible
Customizable treatment planning and 360-degree targeting capability provide the flexibility to treat men with primary or recurrent prostate cancer, obstructive BPH or a combination of both
Exceptionally Precise
Real-time MRI temperature monitoring enables gradual, gentle heating of prostate tissue to achieve cell death, adjusting the energy throughout the procedure degree by degree.
Remarkably Durable
The TULSA Procedure has demonstrated durable efficacy and safety, supported by 70+ peer reviewed publications several with five-year clinical outcomes.
Uncompromisingly Safe
MRI guidance, real-time monitoring, and precise control ensures accuracy, minimizing complications and prioritizing patient well-being.
Suitable For a Wide Range of Prostate Cancer and BPH Patients
Benign
BPH, any size or shape
Organ Confined Prostate Cancer
Combination prostate cancer & BPH
Lesion targeted focal ablation
Whole-gland customized for Quality of life
Salvage
Second line treatment after failed local therapy
Locally Advanced
Palliative debulking & symptom relief
In Use by Clinicians at Many of North America's Leading Medical Centers
TULSA-PRO patients are in better overall health after treatment compared to RP
Significantly Better Overall health During First Month Post Treatment*
Backed by 70+ peer-reviewed publications, including:
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
Klotz et al, The Journal of Urology (2021)
Read the publicationPivotal Study of MRI Guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: 5-Year Follow Up
Eggener, Scott, et al, Society of Urologic Oncology (2023)
Read the publicationSalvage transurethral ultrasound ablation (TULSA) for localized radio-recurrent prostate cancer: 12-month safety and oncological outcomes
Anttinen et al, EAU 2023 Annual Congress (abstract A0965), The Journal of Urology (2023)
Read the publicationMR Imaging in Real Time Guiding of Therapies in Prostate Cancer
Viitala et al, BJU Int (2025)
Read the publicationA brief overview of how TULSA-PRO works
Hear from your colleagues on PRO-TALK
Access an educational platform created for physicians by physicians that connects you with webinars, thought leaders, and other experts to uncover new trends, advancements in medical technologies, and research relating to prostate health.
Get Access